NCT06316973View on ClinicalTrials.gov

A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 7, 2024

Primary Completion Date

May 30, 2024

Study Completion Date

June 6, 2024

Conditions
Substance Use DisordersMethamphetamine AbuseMethamphetamine Intoxication
Interventions
DRUG

CS-1103

CS-1103 for infusion

DRUG

Sterile Saline

Sterile Saline for Injection

Trial Locations (1)

66212

Dr. Vince Clinical Research, Overland Park

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Clear Scientific, Inc.

INDUSTRY